Source-grounded facts extracted from Pluri Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Doron Shorrer was elected as Director at Pluri Inc..
“On June 19, 2026, the Board elected Mr. Doron Shorrer to serve as a member of the Board, effective immediately, to fill an existing vacancy on the Board created by the end of the service of Mr. Ajchenbaum”
Eitan Ajchenbaum departed as Director at Pluri Inc..
“Mr. Eitan Ajchenbaum was not re-elected to the Board and therefore ceased to serve as a director and as a member of the respective committees on which he served, effective from the close of day of the 2026 Annual Meeting.”
Pluri Inc. shareholders approved Ratification of the selection of Kesselman & Kesselman, Certified Public Accountants (Isr.), a member firm of PricewaterhouseCoopers International Limited, as independent registered public accounting firm of the Company for the fiscal year ending June 30, 2026. at the 2026-06-15 meeting.
“Proposal No. 2 - Ratification of the selection of Kesselman & Kesselman, Certified Public Accountants (Isr.), a member firm of PricewaterhouseCoopers International Limited, as independent registered public accounting firm of the Company for the fiscal year ending June 30, 2026. For Against Abstain Broker Non-Votes 7,558,826 20,364 2,007 N/A”
Pluri Inc. shareholders voted on Election of Directors at the 2026-06-15 meeting.
“Proposal No. 1 - Election of Directors The shareholders cast the following votes for the following individuals nominated as directors of the Company to hold office until the next annual meeting of shareholders and until their successors shall have been duly elected and qualified. Director Name For Against Abstain Broker Non-Votes Alexandre Weinstein 6,467,999 33,238 16,135 1,063,825 Eitan Ajchenbaum 2,830,098 3,668,436 18,838 1,063,825 Rami Levi 6,480,813 20,891 15,668 1,063,825 Maital Shemesh-Rasmussen 6,486,725 20,843 9,804 1,063,825 Yaky Yanay 6,466,339 48,768 2,265 1,063,825”
Pluri Inc. entered into Advance Subscription Agreement with Chutzpah Holdings LP valued at $1,250,000 (effective 2026-06-14).
“On June 14, 2026, Pluri Inc. (the “Company”) entered into an Advance Subscription Agreement (the “Advance Subscription Agreement”) with Chutzpah Holdings LP (the “Purchaser”)”
Pluri Inc. entered into Securities Purchase Agreement with Chutzpah Holdings LP valued at $2.5 million gross proceeds (effective 2026-03-24).
“On March 25, 2026, Pluri Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”), effective as of March 24, 2026, with Chutzpah Holdings LP (the “Purchaser”), a limited partnership beneficially owned by Mr. Alexandre Weinstein, a non-U.S. investor and an existing shareholder and director of the Company (“Mr. Weinstein”), relating to a private placement offering (the “Offering”) of: (i) 625,000 common shares, par value $0.00001 per share (the “Common Shares”) of the Company, and (ii) warrants (the “Common Warrants”) to purchase up to 625,000 Common Shares.”
Pluri Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).
“January 20, 2026, Pluri Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with Nasdaq Listing Rule 5550(b)(2), which requires the Company to maintain a minimum of $35 million in market value of listed securities (“MVLS”) for continued listing on The Nasdaq Capital Market (the “MVLS Requirement”), nor is it in compliance with either of the alternative listing standards, including having stockholders’ equity of at least $2.5 million or net income of $5”
Pluri Inc. entered into Securities Purchase Agreement with Chutzpah Holdings LP valued at approximately $2.5 million (effective 2025-12-08).
“On December 8, 2025, Pluri Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with Chutzpah Holdings LP (the “Purchaser”), a limited partnership beneficially owned by Mr. Alexandre Weinstein, a non-U.S. investor and an existing shareholder and director of the Company (“Mr. Weinstein”), relating to a private placement offering (the “Offering”) of: (i) 625,000 common shares, par value $0.00001 per share (the “Common Shares”) of the Company, and (ii) warrants (the “Common Warrants”) to purchase up to 625,000 Common Shares. The combined purchase price for each Common Share and Common Warrant is $4.00. The Common Warrants will be exercisable immediately at an exercise price of $4.25 per share and will be exercisable until June 30, 2026. The Common Warrants contain customary anti-dilution provisions and are subject to a 35% beneficial ownership limitation. The Securities Purchase Agreement contains customary representations, warranties and”
Pluri Inc. received a nasdaq extension granted notice regarding stockholders equity (rules 5550(b)(1)).
“epartment of The Nasdaq Stock Market LLC, or Nasdaq, notifying the Company that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires the Company to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing on The Nasdaq Capital”
Pluri Inc. received a nasdaq extension granted notice regarding stockholders equity (rules 5550(b)(1)).
“epartment of The Nasdaq Stock Market LLC, or Nasdaq, notifying the Company that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires the Company to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing on The Nasdaq Capital”
Liat Zalts was appointed as Chief Financial Officer and Treasurer at Pluri Inc..
“On July 2, 2024, the Board of Directors of the Company appointed Liat Zalts, age 40, to serve as the Company’s Chief Financial Officer and Treasurer effective as of September 30, 2024.”
Chen Franco-Yehuda resigned as Chief Financial Officer at Pluri Inc..
“On June 30, 2024, Ms. Chen Franco-Yehuda notified Pluri Inc. (the “Company”) of her resignation from her position as Chief Financial Officer, Treasurer and Secretary of the Company, which will become effective as of September 30, 2024.”
Pluri Inc.: Effected a 1-for-8 reverse stock split of common shares, effective April 1, 2024 (effective 2024-04-01).
“On March 27, 2024, Pluri Inc. (the “Company”) filed a Certificate of Change (the “Certificate”) with the secretary of state of Nevada relating to a 1-for-8 reverse share split of the Company’s authorized common shares, which will take effect on April 1, 2024 (the “Reverse Split”).”
Pluri Inc. entered into Sales Agreement with A.G.P./Alliance Global Partners valued at up to $10 million (effective 2024-02-13).
“On February 13, 2024, Pluri Inc. (the “Company”), entered into a Sales Agreement , (the “Sales Agreement”), with A.G.P./Alliance Global Partners (“A.G.P.”), as agent, pursuant to which the Company may issue and sell its common shares, par value $0.00001 per share (the “common shares”) having an aggregate offering price of up to $10 million from time to time through A.G.P.”
Pluri Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).
“April 19, 2023, Pluri Inc., a Nevada Corporation (the “Company”), received a written notification (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that for 30 consecutive trading days preceding the date of the Notice, the bid price of the Company’s common shares, par value $0.00001 per share (the “Common Shares”), had closed below the $1.00 per share minimum required for continued listing on The Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”). Pursuant t”
Lorne Abony was appointed as Director at Pluri Inc..
“On July 11, 2023, the board of directors (the “Board”) of Pluri Inc. (the “Company”) appointed Mr. Lorne Abony to serve as a member of the Board, effective immediately, to hold office until the next meeting of shareholders of the Company at which directors are being elected or as set forth in the Company’s bylaws.”
Pluri Inc. shareholders approved To consider and approve, by a nonbinding advisory vote, the compensation of the Company’s named executive officers. at the 2023-04-27 meeting.
“Proposal No. 4 — To consider and approve, by a nonbinding advisory vote, the compensation of the Company’s named executive officers. For Against Abstain Broker Non-Votes 15,349,115 732,188 121,951 8,241,890”
Pluri Inc. shareholders approved Ratification of the selection of Kesselman & Kesselman, Certified Public Accountants (Isr.), a member firm of PricewaterhouseCoopers International Limited, as independent registered public accounting firm of the Company for the fiscal year ending June 30, 2023. at the 2023-04-27 meeting.
“Proposal No. 3 — Ratification of the selection of Kesselman & Kesselman, Certified Public Accountants (Isr.), a member firm of PricewaterhouseCoopers International Limited, as independent registered public accounting firm of the Company for the fiscal year ending June 30, 2023. For Against Abstain Broker Non-Votes 24,023,539 300,657 120,948 N/A”
Pluri Inc. shareholders approved To approve an amendment to the Articles of Incorporation of the Company to increase the number of authorized common shares from sixty million (60,000,000) shares, par value $0.00001 per share, to three hundred million (300,000,000) shares, par value $0.00001 per share. at the 2023-04-27 meeting.
“Proposal No. 2 — To approve an amendment to the Articles of Incorporation of the Company to increase the number of authorized common shares from sixty million (60,000,000) shares, par value $0.00001 per share, to three hundred million (300,000,000) shares, par value $0.00001 per share. For Against Abstain Broker Non-Votes 22,862,121 1,429,223 153,800 N/A”
Pluri Inc. shareholders approved Election of Directors at the 2023-04-27 meeting.
“Proposal No. 1 — Election of Directors The stockholders elected the following individuals as directors of the Company to hold office until the next annual meeting of shareholders and until their successors shall have been duly elected and qualified. Director Name For Against Abstain Broker Non-Votes Zami Aberman 15,826,393 337,697 39,164 8,241,890 Doron Birger 15,627,833 482,377 93,044 8,241,890 Rami Levi 15,704,126 409,116 90,012 8,241,890 Maital Shemesh-Rasmussen 15,723,504 385,670 94,080 8,241,890 Yaky Yanay 15,664,217 499,261 39,776 8,241,890”
Pluri Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).
“April 19, 2023, Pluri Inc. (the “Company”) received a letter (the “Notice”) from The Nasdaq Stock Market (“Nasdaq”) advising the Company that for 30 consecutive trading days preceding the date of the Notice, the bid price of the Company’s common shares had closed below the $1.00 per share minimum required for continued listing on the Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”). The Notice has no effect on the listing of the Company’s common shares at this time, and the Company’s common shares continue to trade on the Nasdaq Global Marke”
Pluri Inc. entered into Securities Purchase Agreement with accredited and non-U.S. investors (effective 2022-12-19).
“On December 13, 2022, the Company executed securities purchase agreements to sell, at a purchase price of $1.03 per share, up to 5,579,883 Common Shares and Warrants to purchase up to 5,579,883 Common Shares, with an exercise price of $1.03 per share and a term of three years.”
Doron Birger was appointed as Director at Pluri Inc..
“On July 15, 2021, the board of directors, or the Board, of Pluristem Therapeutics Inc., or the Company, appointed Prof. Varda Shalev and Mr. Doron Birger to serve as members of the Board, effective immediately,”
Varda Shalev was appointed as Director at Pluri Inc..
“On July 15, 2021, the board of directors, or the Board, of Pluristem Therapeutics Inc., or the Company, appointed Prof. Varda Shalev and Mr. Doron Birger to serve as members of the Board, effective immediately,”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.